Atlas Trials

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

Clinical trial NCT05040984 · UNKNOWN

Trial details

NCT number
NCT05040984
Sponsor
Far Eastern Memorial Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Overactive Bladder Syndrome
Start date
2021-04-30
Primary completion
2024-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.